Prevalence, prescription patterns, and quality of life of anaemia in adults with chronic renal disease
Open Access
- 30 December 2023
- journal article
- research article
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 21 (4) , 785-792
Abstract
Introduction and aim. Anaemia is a chronic kidney disease (CKD) condition characterised by a decline in glomerular filtration rate (GFR) and impaired kidney function. The aim of this study was to assess the prevalence, prescribing patterns, and quality of life of anaemia in patients with chronic renal disease who were adults (>18 years of age) at a tertiary care hospital. Material and methods. Data on demographic characteristics, laboratory results, medication prescriptions, and quality of life assessments were collected. Statistical tests were performed to determine associations between anaemia prevalence and factors like age, gender, and CKD stage. The study included 132 patients, with a gender distribution of 89 men and 43 women. Results. The most frequently prescribed drugs are epoetin (15.06%), multivitamins (14.82%), iron (10.65%), folic acid (10.22%), calcium carbonate (8.17%), calcitriol (5.6%), and omeprazole (4.22%). The cardiovascular system, blood disorders, and blood-producing organs come after the gastrointestinal tract and metabolism in the first anatomical level of the ATC classification. Conclusion. It suggests hospital audits and recommendations for improved prescription practices. Further investigation into anaemia causes and drug class appropriateness is needed, and implementing improvements could potentially improve health outcomes.Keywords
This publication has 38 references indexed in Scilit:
- The effect of renal replacement therapy on health-related quality of life in end-stage renal disease: a meta-analysisClinical and Experimental Nephrology, 2023
- Health-related quality of life of Chinese patients with chronic kidney disease: a study based on four EQ-5D-3L value setsScientific Reports, 2023
- Perfluoroalkyl substances (PFASs) exposure and kidney damage: Causal interpretation using the US 2003–2018 National Health and Nutrition Examination Survey (NHANES) datasetsEnvironmental Pollution, 2021
- SAT-220 QUALITY of LIFE and HEALTH RELATED QUALITY OF LIFE in PATIENTS with END STAGE KIDNEY DISEASEKidney International Reports, 2020
- The Impact of Anemia Treatment on Health-Related Quality of Life in Patients With Chronic Kidney Disease in the Contemporary EraAdvances in Chronic Kidney Disease, 2019
- SUN-098 HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC KIDNEY DISEASEKidney International Reports, 2019
- The Association Hemoglobin Levels with Health-Related Quality of Life of Patients with Chronic Kidney DiseaseValue in Health, 2017
- Evaluation Of Health-Related Quality Of Life Among Malaysian Non Dialysis Dependent Chronic Kidney Disease PatientsValue in Health, 2017
- Health-Related Quality of Life for Patients with Chronic Obstructive Pulmonary Disease in South KoreaValue in Health, 2014
- Assessment of Health-Related Quality of Life Among Patients With Chronic Kidney DiseaseAdvances in Chronic Kidney Disease, 2007